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Background: Experience of myocardial infarction (MI) negatively affects different aspects of 
health-related quality of life (HRQoL). 
Objectives: This study aimed to examine trends in HRQoL of MI patients and to identify 
demographic, clinical and psychosocial predictors of HRQoL at three months.  
Methods: A total of 150 patients in South Korea were completed the study questionnaires at 
baseline. After three months from discharge, 136 participants completed follow-up 
questionnaires, including the Korean version of the MacNew Quality of Life after Myocardial 
Infarction Questionnaire (MacNew).  
Results: HRQoL significantly improved over three months. Younger age, ST-elevation MI, 
and higher LVEF, lower level of depression, better understanding of the illness and higher 
perceived social support at baseline were associated with better HRQoL at three months.   
Conclusion: Providing adequate information about the illness and social support as well as 







Experience of myocardial infarction (MI) poses a threat to health-related quality of life 
(HRQoL).1 Within the first year after MI2, about 20% of patients experience persistent 
symptoms including fatigue, sleep disturbance and shortness of breath as well as 
reoccurrence of MI, stroke, or death3. It is common that patients after MI report lower 
HRQoL scores than those without MI; however, HRQoL scores improve in most patients 
over time.4 The results of a longitudinal study conducted by Eriksson et al.5 showed that 
patients’ HRQoL, measured by the Short Form 36 Health Survey Questionnaire (SF-36), was 
lower than their partners and those without the experience of MI at a one-month follow-up. 
However, HRQoL of MI patients showed improvement with higher scores than their partners 
or those without MI over time, at seven months, 13 months, and 25 months from MI. 
Similarly, another study found that improvement of HRQoL in patients with MI was 
statistically significant from four weeks to six months, as measured with both the Medical 
Outcomes Short Form-12 (SF-12) and the Seattle Angina Questionnaire (SAQ).6  
Multiple factors were reported to affect HRQoL of patients after MI.4 These factors included 
female gender, living alone and low education level and higher depression, anxiety and stress. 
Disease-related factors such as severity of MI and the associated symptoms were also found 
to be negatively associated with HRQoL post-MI. In addition, MI affects different aspects of 
HRQoL, including the physical, emotional and social functioning of patients. Patients’ 
psychological experiences including depression, anxiety, stress, level of social support, 
perception of the disease, and self-efficacy are also associated with HRQoL.7  
Assessment of HRQoL can supplement the traditional measures of health outcomes as this 
subjective report represents the patient-centred health status individually in broader aspects. It 
can also be assumed that diminished HRQoL negatively affects morbidity and mortality in 




concept thus could lead to a broader understanding of patients’ recovery status.8 
Understanding those factors that contribute to HRQoL post-MI, particularly modifiable 
factors, can open a window of opportunities to improve recovery experience and disease 
outcomes of patients post-MI. Although some studies have examined the relationships 
between different demographic, clinical and psychological factors and HRQoL after MI, few 
studies have investigated the predictors of HRQoL using robust statistics to enable 
development of reliable models. These studies are particularly scarce in Asian countries 
including South Korea.  
The purposes of the current study were to examine the trends in HRQoL of patients and to 
identify the role of different demographic, clinical and psychosocial variables in predicting 
HRQoL of these patients at the three-month follow-up. 
 
Methods 
Overview of the design 
This study used a longitudinal observational design to examine the trends in changes of 
HRQoL, from baseline to three months, in patients with MI in South Korea and to identify 
factors predicting HRQoL of the patients at three months post-MI. The majority of infarct 
healing occurs within 3–4 months of MI9 and most patients can resume their pre-illness 
activities including returning to work within three to six months after MI, positively affecting 
their emotional well-being.10 Therefore, as the patients’ functioning status improves, 
improvement in HRQoL is also expected.  
Treatment of acute myocardial infarction (AMI) in South Korea includes reperfusion 
strategies using pharmaceutical interventions, percutaneous coronary intervention (PCI) or 
coronary artery bypass graft. More than 90% of patients with acute MI undergo drug-eluting 




prescription of medical therapy for secondary prevention has been reported to be 
suboptimal.11 After discharge from hospital, patients visit an outpatient clinic two or three 
times within the first month and then once or twice a month for the next three months.  
Human subjects 
Participants were recruited from the comprehensive cardiovascular centres of two tertiary 
hospitals in the southern part of South Korea. They were asked to complete study 
questionnaires at baseline (within one week after MI) and at three-month follow up.  
Inclusion/exclusion criteria 
Inclusion criteria required admission with a diagnosis of either ST-elevation myocardial 
infarction (STEMI) or non-ST elevation myocardial infarction (NSTEMI), ability to 
understand and speak Korean, be a Korean resident, ability to understand the study procedure 
and give an informed consent. Patients were excluded if they had cognitive impairment or if 
they were participating in other interventional studies that might have affected the results of 
the current study. Patients’ cognitive status, capacity to provide consent, and to understand 
the study questionnaires were assessed prior to enrolment in accordance with the Fan et al.’s 
two step approach.12 A charge nurse in each study site firstly confirmed the patient’s ability 
to participate in the study, and then each patient was asked to state their full name and answer 
which colour they had seen among one of three sheets of coloured paper. After the cognitive 
assessment, patients who signed the consent form were subsequently enrolled in the study.  
Rationale for the sample size 
The formula of ‘N > 50+8* the number of independent variables’13 was used to calculate the 
study sample size. Using this formula, a sample size of 138 was needed to allow for inclusion 





The Institutional Review Boards of the participating hospitals (PNUH IRB no. H-1505-008-
029 and PNUYH IRB no. 05-2015-072) and the Human Research Ethics Committee of the 
involving university (UTS HREC Approval No. 2015000254) approved the ethics of the 
study. Potential participants were provided with information about the study verbally and in 
writing in Korean. Participations who were interested in the study gave consent and were 
enrolled in the study. The confidentiality privacy and volunteer participation were maintained 
throughout the study. Participants were assured that their participation was completely 
voluntary and that they could withdraw at any time they wished. The individual’s 
participation was not disclosed to others and the data collection was held individually in a 
room where the patients’ privacy could be protected. Follow-ups were scheduled according to 
participants’ preferences to minimise inconvenience. Data collection was completed by the 
principle investigator whose first language is Korean (KK). Two cardiologists and several 
nurse managers were consulted to discuss strategies for participant recruitment, study 
questionnaires, and ethical considerations. Figure 1 describes the process of screening, 
enrolment and follow-up of the study participants. A total of two hundred and fifteen 
consecutive patients were screened for the study inclusion criteria from August 2015 to 
February 2016; of whom 17 patients were excluded due to poor hearing, five patients were 
discharged before enrolment, and one patient was unconscious. The remaining eligible 
patients were invited to participate in the study. Among those who were invited to the study, 
23 patients declined to participate because of perceived poor health condition, including 
dyspnoea, pain and tremor and 19 patients declined the invitation without giving a specific 
reason. 
A total of 150 patients (69.8%), who provided informed consent were enrolled in the study 




three-month follow-up. The participants were asked to complete the questionnaires by 
themselves or the researcher read out the questions to the participant, obtained, and recorded 
their responses. Of the 150 participants at baseline, ten were lost to follow-up and four passed 
away. As a result, 136 participants completed the three-month follow-up questionnaires. The 
three-month follow-up questionnaires were completed in a face-to-face session at an 
outpatient department during a routine follow-up check-up. Some participants who did not 
have enough time to complete the three-month follow-up questionnaires at the outpatient 
department or the researcher failed to meet them at their follow-up appointment completed 
the follow up questionnaires over the telephone. 
 
Figure 1. Flow diagram of participants with MI from screening, recruitment, withdrawal to completion. 
 
 
Assessed for eligibility (n=215)  
Enrolled=150 
Excluded (n= 65)  
 Refusal due to poor health 
condition (n=23)  
 Declined without any reason 
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 Discharged before enrolment 
(n=5) 
 Being unconscious (n=1) 
Total participants completed the 
questionnaires at baseline=150 
Participants completed the 
questionnaires at three months 
(follow-up) =136 





Variables and measures 
Variables and conceptual framework 
A thorough review of previous literature7 and the revised Wilson & Cleary model for 
HRQoL14 guided the selection of independent variables for the study. The participants’ 
baseline psychosocial status (depression, anxiety, stress, illness perception, and social 
support), demographic factors (age, gender, education level and subjective financial status), 
and clinical factors (type of MI and LVEF) were examined for their contribution to HRQoL 
of the participants at the three-month follow-up. 
Demographic and clinical profiles 
Information on demographical profiles of the participants was collected, which included: age, 
gender, marital status, education level, employment status and self-assessed financial 
situation (categorised as excellent/good/only fair/poor). Information on participants’ clinical 
profiles included: type of MI (STEMI/NSTEMI), smoking (non-smoker/previous 
smoker/current smoker), alcohol consumption (yes/no), LVEF, history of high blood 
pressure, diabetes, stroke, other heart diseases, previous MI and other comorbidities. This 
information was collected from the medical records of the participants after obtaining their 
consent.  
Psychosocial profile 
Depression, anxiety, and stress 
Among psychosocial factors studied in previous literature, depression, anxiety and stress has 
been the most commonly examined factors negatively affecting HRQoL of patients with 
MI.15-17 We used the Korean version of the DASS 2118 to assess the participant’s 
physiological status. The DASS 21 is the short form of the DASS 42, consisting of 21 items 




ranging from 0 to 63, with higher scores indicating greater depression, anxiety and stress.19 
The measurement can be divided into three dimensions of depression, anxiety and stress. 
Each dimension encompasses seven items with the total scores of the subscales ranging from 
0 to 21.19  
DASS 21 is a valid tool. In the original study, the internal consistencies of the subscales have 
been reported as 0.91 for depression, 0.84 for anxiety and 0.90 for stress (Lovibond & 
Lovibond 1995). In a Korean study using the Korean version of the DASS 21, the alpha 
coefficients were ranged from 0.72 to 0.81 for the subscales of depression, anxiety and 
stress.20 In the current study, the alpha coefficient for the total scale was 0.86, and for the 
subscales of depression 0.85, anxiety 0.52, and stress 0.80. We included the total scores of the 
DASS 21 in the regression analysis. 
Illness perception  
The available evidence suggested that patients with more positive illness perceptions 
following MI showed better quality of life.21 Thus, this study examined participants’ 
understanding of their MI, using a single item extracted from the Brief Illness Perception 
Questionnaire (B-IPQ). This item was scored on a Likert type scale ranging from 0 (“don’t 
understand at all”) to 10 (“understand very clearly”).22 The Korean version of the item was 
prepared for the purpose of this study. 
Social support 
The ENRICHD Social Support Inventory (ESSI) has been developed to measure the social 
support of patients with coronary heart disease, in particular, patients with MI. This 
questionnaire consists of seven items addressing different types of social support including 
structural, instrumental, and emotional support. Response rate for all the items ranges from 1 




“no”.23 The seven items can be summed as the total score ranging from 8 (no support) to 34 
(maximum level of support).24 The validation studies of the scale on the cardiac patient 
population have shown high internal consistencies, with alpha coefficients ranging from 0.88 
to 0.94.24 A Korean version of the scale was prepared for the purpose of this study and the 
alpha coefficient of the study sample was 0.93. The ESSI was firstly translated into Korean 
by the principal researcher whose first language is Korean, and then reviewed by two health 
professionals and two laypersons who were Korean native speakers. 
Health-related quality of life 
The MacNew Quality of Life after Myocardial Infarction Questionnaire (MacNew) is a 
disease specific valid tool to measure HRQoL of patients with MI. For the purpose of this 
study, the tool was translated into Korean language and validated on a sample of Korean 
patients with MI. The MacNew includes 27 items with responses ranging from 1 to 7 on a 
seven point Likert scale. The items of this instrument fall into three physical (13 items), 
emotional (14 items) and social dimensions (13 items)25, 26, although loadings of items onto 
each construct vary slightly across studies. The total mean score and each domain can be 
calculated as a mean score with a range between 1 and 7, with higher scores representing 
better HRQoL. The minimal important difference (MID) on the global MacNew and the three 
subscales is determined by 0.50 points as a significant change.25 The reliability of the total 
MacNew has been well established in a plethora of previous studies, with Cronbach's alpha 
coefficients ranging from 0.85 to 0.94.27-29 The Cronbach's alpha coefficient of the Korean 
MacNew in the current study was also high at 0.90 for the total scale, and 0.86, 0.85 and 0.88 






Data were analysed using SPSS version 24.0 (SPSS Inc., Chicago, IL, USA). A descriptive 
analysis of participants’ characteristics was performed using means, standard deviations 
(SD), frequencies and percentages. The MacNew scores were normally distributed, thus 
paired-samples t-tests were used to examine changes between baseline MacNew and three-
month follow-up scores. Tolerance, variance inflation factor (VIF) and correlations between 
the independent variables were analysed for multicollinearity. The results were indicated the 
absence of multicollinearity with a tolerance value of higher than 0.10, a VIF value of below 
10 or Pearson correlation coefficients of lower than 0.90.13 Thus, 11 independent variables 
were included in the backward stepwise regression model. At each elimination step, one or 
two most insignificant factors were removed from the model until only significant predictors 




The mean age of participants at baseline was 64.63 (SD=11.48) years, with a range of 21 to 
86 years. Most of the participants were aged 55 years or older (n=120, 80.0%), male (n=107, 
71.3%), married (n=129, 86.0%) and educated at a middle school level or higher (n=110, 
73.3%). Forty per cent of the participants (n=60) were employed at the time of enrolment, but 
only 14.0 % (n=21) perceived their financial situation as ‘excellent’ or ‘good’. The mean 
value of LVEF was 50.86% (SD=10.80) with a range from 17% to 70%. One third of the 
patients in this study (n=50, 33.3%) were current smokers and 28.7% of them (n=43) 
answered ‘yes’ to the drinking question. The demographic and clinical characteristics of the 




Table 1. Participants’ demographic and clinical characteristics at baseline (n=150) 
Demographic factors n % 
Age (years) <55 30 20.0 
 55-64 43 28.7 
 65-74 43 28.7 
  75 ≤ 34 22.6 
Gender Female 43 28.7 
 Male 107 71.3 




Level of education Primary or less 40 26.7 
Middle school 25 16.7 
High school 54 36.0 
Undergraduate or more 31 20.6 
Employment status Employed 60 40.0 
Unpaid family workers/Retired / 
Unemployed 
90 60.0 
Financial status (Subjective) Excellent / Good 21 14.0 
Only fair / Poor 129 86.0 
Clinical factors  
Type of MI STEMI 57 41.9 
 NSTEMI 79 58.1 
Smoking Non-smoker 85 56.7 
 Previous smoker 15 10.0 
 Current smoker 50 33.3 
Alcohol consumption Yes 43 28.7 
 No 107 71.3 
Medical Characteristics Hypertension:                        Yes 75 50.0 
                                                No 75 50.0 
 Diabetes:                                Yes 47 31.3 
                                                No 103 68.7 
 Stroke:                                   Yes 8 5.3 
                                                No 142 94.7 
 Other heart disease:               Yes 25 16.7 
                                                No 125 83.3 
 Previous MI:                         Yes 37 24.7 
                                                No 113 75.3 
 Other comorbidities:             Yes 58 38.7 
                                                No 92 61.3 
LVEF = Left Ventricular Ejection Fraction; MI = Myocardial Infarction; NSTEMI = non-ST elevation myocardial infarction; SD = Standard Deviation; STEMI 
= ST-elevation myocardial infarction. 
Changes in HRQoL 
The changes in total scores of HRQoL and the subscales from baseline to three-month 




showed statistically significant improvements in all the dimensions of the MacNew with a 
mean difference of 0.98 for emotional, 1.11 for physical, and 1.06 for social dimensions. The 
total score of the MacNew also improved significantly from baseline to three-month follow-
up, with the mean difference of 1.03.  
Table 2. Changes in the MacNew scores of the participants over three months (n =136)  
 Baseline Follow-up Mean difference 
(95% CI) t p Variables (range) Mean SD Mean SD 
MacNew total 4.51 0.81 5.54 0.78 1.03 (0.88, 1.17) 13.896 0.000 
     Emotional 4.42 0.82 5.40 0.85 0.98 (0.81, 1.14) 11.617 0.000 
     Physical 4.43 0.99 5.55 0.85 1.11 (0.95, 1.27) 13.834 0.000 
     Social 4.83 0.93 5.89 0.82 1.06 (0.89, 1.23) 12.356 0.000 
MacNew = MacNew Quality of Life after Myocardial Infarction Questionnaire; SD = Standard Deviation. 
Notes: The MacNew scores are the average of responses over relevant items. 
 
 
Predictors of HRQoL at three-month follow-up 
Table 3 shows the results the backward elimination stepwise regression analysis. The first 
model of the stepwise regression included a total of 11 variables—age, gender, the level of 
education, perceived financial status, type of MI (STEMI/NSTEMI), LVEF, depression, 
anxiety, stress, illness perception, and social support. Of these variables, age, LVEF, 
depression, stress, illness perception, and social support were statistically significant. At the 
next step, the two least significant variables—education level and perceived financial 
status—were eliminated, resulting in gender, type of MI and anxiety to become statistically 
insignificant predictors. Gender and anxiety, as the least significant predictors were removed 
from the model at the third step, resulting in type of MI becoming a statistically significant 
predictor, while stress showed the least correlation with HRQoL. Following the removal of 
stress in the next step, all the six remaining variables showed statistically significant 
correlations with HRQoL at three months post-MI. These predictors included age, type of MI, 




p=0.008) was closely associated with better HRQoL at three months. Being diagnosed with 
STEMI (β=-0.163, t=-2.119, p=0.036) or having higher LVEF at baseline (β=0.207, t=2.606, 
p=0.010) were significant predictors of higher HRQoL at three months. Higher score of 
depression at baseline (β=-0.201, t=-2.644, p=0.009) was closely associated with lower 
HRQoL at three months. In addition, patients’ better understanding of their illness (β=0.213, 
t=2.755, p=0.007) or perceived higher social support at baseline (β=0.199, t=2.515, p=0.013) 
were significant predictors of better HRQoL at three months. The final model of the current 





Table 3. Predictors of HRQoL at three-month follow-up using the backward elimination stepwise regression analysis   
β = Standardised β; B-IPQ 7 = Brief Illness Perception Questionnaire 7th item; ESSI = ENRICHD Social Support Instrument; LVEF = Left Ventricular Ejection Fraction; Tol = Tolerance; VIF = Variance Inflation Factor. 
* Significant at the level of p<0.05.  
**Significant at the level of p<0.01. 
 
  
 Collinearity  Step 1 Step 2 Step 3 Step 4 
Demographic 
factors Tol. VIF β t-value p β t-value p β t-value p β t-value p 
Age 0.738 1.354 -0.175 -2.034 0.044* -0.180 -2.239 0.027* -0.206 -2.602 0.010* -0.216 -2.715 0.008** 
Gender 0.758 1.318  0.098  1.148 0.253  0.112  1.390 0.167 - - - - - - 
Education level 0.543 1.840  0.035  0.352 0.726 - - - - - - - - - 
Financial status 0.726 1.377  0.095  1.097 0.275 - - - - - - - - - 
Clinical factors             
Type of MI 0.887 1.128 -0.124 -1.571 0.119 -0.133 -1.706 0.090 -0.166 -2.188 0.031* -0.163 -2.119 0.036* 
LVEF 0.827 1.210  0.195  2.391 0.018*  0.180  2.277 0.024*  0.204  2.601 0.010*  0.207  2.606 0.010* 
Psychosocial factors             
Depression 0.603 1.660 -0.252 -2.637 0.009** -0.238 -2.527 0.013* -0.272 -3.253 0.001** -0.201 -2.644 0.009** 
Anxiety 0.581 1.722 -0.111 -1.142 0.256 -0.101 -1.048 0.297 - - - - - - 
Stress 0.678 1.476  0.203  2.253 0.026*  0.193  2.165 0.032*  0.165  1.946 0.054 - - - 
B-IPQ 7 0.823 1.215  0.191  2.345 0.021*  0.179  2.309 0.023*  0.205  2.674 0.008**  0.213  2.755 0.007** 
ESSI 0.723 1.383  0.244  2.803 0.006**  0.224  2.797 0.006**  0.227  2.849 0.005**  0.199  2.515 0.013* 
   R2 = 0.320, adjusted R2 = 0.260 R2 = 0.314, adjusted R2 = 0.265 R2 = 0.295, adjusted R2 = 0.257 R2 = 0.274, adjusted R2 = 0.241 





The results of our study suggested that HRQoL of patients with MI improved significantly 
within the first three months after MI. Predictors of better HRQoL at three months included 
younger age, STEMI diagnosis, higher LVEF, illness perception, perceived social support, 
and lower depression symptoms at baseline.  
Oginska-Bulik30 found that younger patients with MI had higher quality of life. This can be 
explained by higher physical functioning in younger patients after MI.31 Moreover, younger 
patients are likely to be treated more intensively in consideration of their physical status.32  
We found that patients diagnosed with STEMI had higher HRQoL at three months post-MI 
compared to those with NSTEMI. This finding seems also consistent with other research 
which showed STEMI patients had higher overall HRQoL than those with unstable angina or 
NSTEMI.33 Few studies have compared HRQoL between patients with STEMI and NSTEMI, 
although disease prognosis is different between these two conditions. Patients diagnosed with 
STEMI are likely to have relatively low mortality at the early stage; however, NSTEMI 
patients tend to have a better health condition in the long-term period.33 As this study focused 
on the early stage of recovery from MI, higher HRQoL scores in patients with STEMI are 
expected. Besides, baseline LVEF was one of significant predictors of HRQoL at three 
months post-MI. This finding is in line with previous studies, which showed that patients 
with lower LVEF had poorer HRQoL later.34, 35 However, a recent study in Korea36 found 
that LVEF was not statistically associated with HRQoL in patients with heart failure. LVEF 
was regarded as the severity of MI37 as this value has been frequently used for measuring 
cardiac function in clinical practice. However, the association between LVEF and HRQoL 
has not been adequately studied in patients with MI.38  
In addition to the demographic and clinical predictors, three psychosocial factors could be 




studies16, 39-41, we found that depression symptoms at baseline were predictive of inferior 
HRQoL at three months. This finding support the results of another Korean study that cardiac 
patients with depression symptoms reported decreased HRQoL, irrespective of their gender.31 
Moreover, depression has been consistently identified as an independent predictor, adversely 
associated with all dimensions of HRQoL—emotional, physical and social—in MI patients in 
different countries.15, 40, 41 
We found that patients’ better understanding of their illness at early stages after MI predicted 
better HRQoL at three months. This finding is in line with the results of a prospective study, 
which reported higher HRQoL scores at six months in patients with more positive illness 
perception at early stages post-MI.39 Overall, research on the relationship between illness 
perception and HRQoL post-MI is scant and further research is needed to better understand 
the role of patient illness perception on recovery from MI.  
In the present study, perceived social support was a predictor of HRQoL at the three-month 
follow-up. This finding supports the results of the Park et al.31 study which reported a 
positive relationship between social support and HRQoL at one month post-MI. We did not 
investigate if the role of social support on HRQoL after MI differently affected men and 
women; however, Park et al. reported that social support had stronger impact on HRQoL of 
Korean women with MI than on men.31 A possible explanation of these results may be that 
Korean people are less likely to visit mental health professionals or clinics, but cope with 
their problems by depending on their family or friends.42 The major features of Korean 
culture can be referred to as familism43 and the communal culture with high solidarity.44 
Moreover, people in South Korea have negative attitudes towards mental health services.45 
These cultural features may influence the patient’s reliance on close personal relationships for 
dealing with their mental health, particularly negative emotions, including depression, a 




relationship between social support and HRQoL in patients with MI outside South Korea, 
have reported similar results. Specifically, researchers in Australia found that at six-month 
follow-up acute MI patients who scored higher in the ESSI showed better HRQoL.32 In 
addition, the influence of perceived social support tended to last up to 12 months after MI 
when HRQoL.46, 47 However, perceived overprotection was negatively associated with 
HRQoL at nine months.48 
The findings of this study have important implications for health care professionals who are 
endeavouring to improve patient disease experience and recovery after MI. Comprehensive 
supportive care is needed to improve the general health status of MI survivors. As found in 
our model of backward elimination regression analysis, interventions to improve HRQoL in 
patients post-MI should focus on modifiable predictors including social support, illness 
perception, and depression management.  
Depression is an independent predictor of poor prognosis and mortality after MI. The 
American Heart Association recommends that all patients with cardiovascular disease should 
be assessed for depression symptoms and treated if needed.49 Korea has the highest suicide 
rate in the world.50 This fact may reflect Korean people generally tend to have negative 
attitudes toward using professional mental health services and thus use them infrequently.45 
Thus, patient counselling, education, and treatment of depression should be combined with 
usual care in the early stage of recovery from MI.  
Further, the relationship between illness perceptions and patient outcome has been well 
documented across different patient groups, including patients with cardiac disease.39 
Therefore, interventions to alter illness perceptions, especially perceptions of consequences, 
may be useful in improving HRQoL following an MI.  
Perceived social support was another significant predictor of HRQoL in patients with MI at 




emotional support, informational support, and instrumental support they received from 
others.23 Based on questions of the ESSI, helping in household tasks, giving advice and trust 
would increase patient’s perception of the social support.23 Therefore, exploring means to 
support patients emotionally, physically, and financially in early days after MI can be 
important in helping the patients to improve their HRQoL, overall health and well-being. Yet, 
perception of overprotection has been shown to have adverse effect on MI patients’ sense of 
well-being. Interventions utilising self-help groups for patients with MI may increase 
perceived social support and thus HRQoL.31 In consideration of the Korean values of 
familism and communal culture, interventions featuring of group support for patients post MI 
may be more effective than individual strategies. 
The findings of this study should be interpreted with the consideration of several limitations. 
First, the final model of regression explained only 27.4 per cent of the total variance for 
HRQoL at three months after MI. This result leads to the fact that HRQoL of MI patients is 
affected by multiple factors worth investigating by future research. Second, our study used a 
relatively small sample size, considering the multifactorial nature of HRQoL, future studies 
should use larger samples to allow for more comprehensive investigation of associated 
predictors. In addition, we included both patients who suffered a first-time MI and patients 
with recurrent MI. It is recommended that future studies compare HRQoL between the two 
groups.  
Conclusions 
The results of this study in the Korean population confirm that HRQoL of patients with MI 
improves over time. At three months post-MI, patients with a higher HRQoL are those who 
are younger, diagnosed with ST-elevation MI, have higher LVEF, lower level of depression, 




indicate that interventions in the form of psychological counselling, patient education, and 
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